MedTech Dive June 3, 2024
After debuting its Lingo device in the U.K. last year, Abbott can now sell the sensor in the U.S.
Dive Brief:
- Abbott received clearance from the Food and Drug Administration for an over-the-counter glucose monitor.
- The device, called Lingo, first debuted in the U.K. last year as a sensor for people who don’t have diabetes to track glucose spikes. Abbott hopes to bring it to the U.S. but has shared few details about its plans.
- With the recent FDA clearance, Abbott will compete with Dexcom for a new category of over-the-counter glucose monitors. Dexcom received FDA clearance for the first over-the-counter CGM in March.
Dive Insight:
Abbott has not yet shared when it plans to roll...
Today's Sponsors
Today's Sponsor